Glenn Whitman, M.D., joined the Johns Hopkins Division of Cardiac Surgery in 2009 as associate professor of surgery. His training began at the University of Pennsylvania, where he was a resident in surgery from 1979 to 1984. He then finished his general surgery training and then completed his training as a cardiothoracic surgeon at the University of Colorado. Thereafter, Dr. Whitman became an assistant professor at the University of Colorado and chief of cardiothoracic surgery at the Denver Veteran’s Administration Hospital, where he remained for two years. In 1990, he returned to his home city of Philadelphia, where he became chief of cardiac surgery at the Medical College of Pennsylvania, formerly Women’s Medical College, the first medical school in the United States to accept women. Dr. Whitman remained there for eight years before moving to the University of Maryland as chief of cardiac surgery. He has served as the director of transplantation and United Network for Organ Sharing representative at Temple University Hospital in Philadelphia, as well as its director of perioperative services, managing preadmission testing, the operating room, and the post-anesthesia care unit. In 2007, he left Temple for Thomas Jefferson Hospital, taking over the responsibilities of running the cardiac surgery intensive care unit. In summer 2009, he was returned to Baltimore to run the cardiac surgery intensive care unit and oversee the performance improvement/quality assurance program for cardiac surgery at Johns Hopkins. Dr. Whitman’s initial research interests were in cardiac ischemia-reperfusion injury and P31 nuclear magnetic resonance of cardiac bioenergetics, for which he received both National Institutes of Health and Department of Veterans Affairs funding. He has since become involved with quality outcome, and has presented at the American College of Surgeons and the Society of Thoracic Surgeons on the difficulties associated with performance improvement and quality assurance in the field of health care, particularly in the ICU. This past year, Dr. Whitman has stepped down from his role as the Chair of the Society of Thoracic Surgery Workforce on Critical Care, a role he had held since 2014. He continues to participate in the content of the Annual Meetings for the Society of Thoracic Surgery, The American Association of Thoracic Surgery, and The STS Fall Critical Care meetings as the Programmatic Co-Chair for Perioperative Care. This past year he has participated in two major consensus statements on postcardiotomy shock (see below) and low ejection fraction CABG patients (awaiting review). 2020 EACTS/ELSO/STS/AATS ExpertConsensus on Post-CardiotomyExtracorporeal Life Support in Adult Patients Ann Thorac Surg 2012;111:327-69. Dr. Whitman is rated as a Distinguished provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Cardiogenic Shock, Restrictive Cardiomyopathy (RCM), Hemolysis, Heart Bypass Surgery, and Heart Transplant.

Robert Benitez is a Cardiologist in Baltimore, Maryland. Dr. Benitez is rated as a Distinguished provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Mitral Valve Regurgitation, Necrosis, Cardiogenic Shock, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Anuj Gupta is a Cardiologist in Baltimore,, Maryland. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Aortic Valve Stenosis, Cardiogenic Shock, Pulmonary Veno-Occlusive Disease, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Samer Najjar is a Cardiologist in Baltimore,, Maryland. Dr. Najjar is rated as a Distinguished provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Heart Failure, Cardiomyopathy, Cardiogenic Shock, Heart Transplant, and Cardiac Ablation.

Jelani Grant is a Cardiologist in Baltimore, Maryland. Dr. Grant is rated as an Advanced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Aortic Valve Stenosis, Heart Failure, Atherosclerosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Thomas Stephen Metkus is an assistant professor of cardiology at the Johns Hopkins University School of Medicine. His research focuses on using cardiac physiology for risk stratification and therapeutics in non-cardiac critical illness such as sepsis and the acute respiratory distress syndrome (ARDS), and optimizing the management of non-cardiac organ failure in primary cardiac diseases such as heart failure and acute coronary syndromes. Dr. Metkus received his undergraduate degree from Boston University College of Engineering. He earned a medical degree from the University of Pennsylvania School of Medicine and completed a residency at Brigham and Women’s Hospital. After completing residency, Dr. Metkus was a clinical fellow at both Harvard Medical School and Johns Hopkins Hospital. Prior to joining the faculty at the Johns Hopkins Medical School he was an instructor of medicine at the Harvard Medical School. His educational focus includes teaching clinical cardiology and critical care, echocardiography, and electrocardiography to students, residents, and fellows at the Johns Hopkins Hospital. Videos Dr. Thomas Metkus. Dr. Metkus is rated as an Advanced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Dr. Sammy Zakaria is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine (JHUSOM). Because he specializes in critical care cardiology, he predominately works in the Cardiac Intensive Care Unit (CICU) at the Johns Hopkins Bayview Medical Center (JHBMC) as well as the Cardiac Care Unit at Johns Hopkins Hospital (JHH). He also serves as the Director of the JHBMC CICU. His practice encompasses most of cardiology, with many of his patients having had life-threatening cardiac issues, such as shock, end-stage heart failure, or multi-organ system failure. He also has an interest in caring for pregnant women with cardiovascular disease, including those with severe preeclampsia, and his clinical research efforts focus on the effects of preeclampsia on the cardiovascular system. Additionally, his other research areas of interest include critical care issues affecting cardiac patients and studying innovations in medical education. Dr. Zakaria is heavily involved in medical education and serves as an educator for students, residents, fellows, and staff. He served as a JHUSOM Colleges Advisor for 10 years and was responsible for teaching and mentoring a cohort of medical students during their time in medical school. In his role as Interim Program Director for the JHBMC Internal Medicine Residency Program, he has helped to increase the JHBMC Internal Medicine residency program’s nationally-recognized reputation for excellence by championing curricular innovations, resident scholarly work, and resident academic careers. He also is a Core Faculty member for the JHH Osler Internal Medicine residency program and for the Johns Hopkins Cardiovascular Disease fellowship. As a result of his efforts in education, he has been honored with multiple teaching awards, including the Outstanding Achievement in Teaching Award from the Johns Hopkins Institute for Excellence in Education. Dr. Zakaria earned his undergraduate degree from the Pennsylvania State University, his medical degree from Jefferson Medical College, and his master of public health degree from the University of Maryland. He trained at Thomas Jefferson University Hospital in Internal Medicine and also practiced there as a faculty attending for one year. He then completed a fellowship in cardiovascular disease at the University of Maryland and subsequently a Critical Care Medicine fellowship at the University of California San Francisco. He joined the Johns Hopkins faculty in 2008. Dr. Zakaria is rated as an Advanced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Apoplexy, Heart Attack, Arterial Embolism, Inappropriate Sinus Tachycardia (IST), and Pacemaker Implantation.

Dr. Anum Minhas attended medical school at Duke University and trained in internal medicine at the University of Michigan, Ann Arbor. During her Cardiology fellowship training at Johns Hopkins University School of Medicine, she served as the Chief Cardiology fellow and was honored to receive the Marie-Josee and Henry R. Kravis Endowed Fellowship and the Lou and Nancy Grasmick Endowed Research Fellowship (2021-2022). She was also awarded the Dlabal Clinical Research award for originality and creativity in research. During her fellowship, she completed additional training and obtained a Master of Health Science with focus in cardiovascular epidemiology as an NIH T32 postdoctoral fellow at the Johns Hopkins Bloomberg School of Public Health. She also completed additional clinical training during fellowship in Advanced Echocardiography, and designed and completed an inaugural fellowship in Cardio-Obstetrics. Dr. Minhas joined the Johns Hopkins Cardiology faculty with a clinical focus in women's cardiovascular health, specifically Cardio-Obstetrics, or cardiac disease around pregnancy. She also attends in the coronary critical care unit and the echocardiography laboratory. She was selected as a recipient of an NIH-sponsored KL2 award through the Clinical Research Scholars Program. Her current research focuses on preventing and managing cardiovascular disease associated with pregnancy complications, such as preeclampsia. She is the recipient of several grants and has coauthored multiple publications and book chapters in women's cardiovascular health. She hopes to use her research to raise awareness of and provide insights into mechanisms of pregnancy-associated cardiac disease and promote health equity in maternal health. Videos Community ConversationMaternal Health Recent News Articles and Media Coverage https://the1a.org/segments/in-good-health-unpacking-heart-disease-in-women/ In Good Health: Medical missteps for women with heart disease, NPR Podcast. Dr. Minhas is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. Her top areas of expertise are Peripartum Cardiomyopathy, Pulmonary Edema, COVID-19, and Cardiomyopathy.

Joban Vaishnav is a cardiologist specializing in heart failure in Baltimore, Maryland. Additionally, she is an assistant professor at the Baltimore-based Johns Hopkins University School of Medicine. She has special interest in amyloidosis. Dr. Vaishnav earned her medical degree from St. Louis University School of Medicine. She completed a residency in internal medicine at The Johns Hopkins Hospital, where she also completed fellowships in cardiology and advanced heart failure and transplant cardiology. Dr. Vaishnav is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. Her top areas of expertise are Cardiac Amyloidosis, Heart Failure, Primary Localized Cutaneous Amyloidosis, Heart Transplant, and Tissue Biopsy.

Rani Hasan is an Interventional Cardiologist in Baltimore, Maryland. Dr. Hasan is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Nisha A. Gilotra is a cardiologist in the Johns Hopkins Medicine Division of Cardiology with expertise in advanced heart failure, including the care of heart transplant and ventricular assist device patients. Dr. Gilotra specializes in inflammatory cardiomyopathies, including sarcoidosis, myocarditis and inherited causes of cardiomyopathy. Dr. Gilotra received her medical degree from Jefferson Medical College in Philadelphia, PA. She completed her medical residency, general cardiology fellowship and advanced heart failure fellowship at Johns Hopkins University School of Medicine. Between fellowships, she served as an Assistant Chief of Service for the Department of Medicine. Dr. Gilotra is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. Her top areas of expertise are Sarcoidosis, Myocarditis, Cardiomyopathy, Heart Transplant, and Endoscopy.

Dr. Ghoreishi is an internationally recognized expert. He brings exceptional skill in open and endovascular aortic repair, including aortic valve repair, Ross operation, valve sparing aortic root repair, innovation in minimally invasive techniques for aortic aneurysm repair, endovascular repair of high risk patients with acute type A or type B aortic dissection, and first-in-human procedures such as the Endo-Bentall repair for aortic dissection. His clinical leadership and innovation have drawn national and international referrals and advanced standards of care in this challenging field. Dr. Ghoreishi has served as Principal Investigator on several federally funded studies through the National Heart, Lung, and Blood Institute (NHLBI) and is a frequent contributor to national guidelines and surgical education symposia. Dr. Ghoreishi is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Aortic Dissection, Cystic Medial Necrosis of Aorta, Thoracic Aortic Aneurysm, Embolectomy, and Heart Bypass Surgery.

Chetan Pasrija, M.D. is a cardiothoracic surgeon in Baltimore, Maryland. He is an assistant professor of surgery at the Johns Hopkins University School of Medicine. Dr. Pasrija specializes in heart and lung transplantation, aortic surgery, and the surgical treatment of ischemic heart disease. He also has a particular interest in chronic thromboembolic pulmonary hypertension. He has published extensively on the topics of heart and lung transplant, massive pulmonary embolism, chronic thromboembolic pulmonary hypertension, and minimally invasive left ventricular assist device implantation. As a trainee, Dr. Pasrija was heavily involved with the surgical implantation and postoperative management of the first cardiac xenotransplant performed in the world at the University of Maryland. During his time as faculty at Vanderbilt University, he was a part of one of the largest heart and lung transplant programs in the United States. This included significant involvement with cutting-edge technologies to expand the donor pool, including normothermic regional perfusion and the Transmedics Organ Care System. Dr. Pasrija was co-surgeon in a combined heart-lung transplant with a groundbreaking 9.5 hour period of time without any blood flow using a novel 10⁰C cooler. He has also performed heart transplants with travel as far as Puerto Rico. Outside of transplantation, Dr. Pasrija is a high-volume cardiac surgeon, with an interest in complex open and endovascular aortic surgery. He performed the first ascending stent in the state of Tennessee, as well as the first total arch replacement without cooling the patient’s body in Tennessee using the Thoraflex device. He earned his Bachelor of Science Degree in Bioengineering at the University of Maryland and his Medical Degree at the University of Maryland School of Medicine. He completed an Integrated Cardiothoracic Surgery residency at the University of Maryland. During his training, he spent time at Vanderbilt University to learn advanced heart failure techniques as well as time at the University of Toronto to learn advanced lung transplant and pulmonary thromboendartectomy techniques. Additionally, he has a Masters in Clinical Research from the University of Maryland. Outside of his clinical interests, Dr. Pasrija is an accomplished investigator. During his post-doctoral research fellowship, he received a competitive American Heart Association post-doctoral fellowship award in addition to institutional awards for excellence in research. His research efforts focus on improving donor preservation with novel perfusion and temperature techniques, improving donor evaluation methods, and establishing novel immunologic therapies for transplant tolerance. Dr. Pasrija is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Mitral Valve Regurgitation, Aortic Valve Stenosis, Aortic Dissection, Embolectomy, and Heart Transplant.

"Originally from Wisconsin, Dr. Czarny attended the University of Wisconsin where he majored in molecular biology. After medical school at the Johns Hopkins University School of Medicine, he completed an internal medicine residency at the Brigham and Women’s Hospital in Boston followed by cardiovascular disease, interventional cardiology, and structural heart disease fellowships at Johns Hopkins. Currently, he is a faculty member in interventional cardiology and performs heart catheterizations and coronary artery stenting for patients with stable coronary artery disease (CAD) and myocardial infarctions (""heart attacks"") at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. He is also a member of the Structural Heart Disease team and performs minimally invasive, catheter-based treatments for structural heart disease at the Johns Hopkins Hospital including transcatheter aortic valve replacement (TAVR) for aortic valve stenosis, valve repair/replacement procedures for mitral valve regurgitation and stenosis, patent foramen ovale closure, atrial septal defect closure, alcohol septal ablation for hypertrophic cardiomyopathy, and left atrial appendage occlusion with the Watchman(TM) device. He sees patients in his structural heart disease clinics at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. Dr. Czarny's research interests include the safety of cardiac stenting at hospitals without cardiac surgery backup and outcomes of catheter-based structural heart procedures.". Dr. Czarny is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Jon R. Resar received his M.D. from the Medical College of Wisconsin in 1985. He completed an internal medicine residency at The Johns Hopkins Hospital and fellowships in cardiovascular medicine and interventional cardiology at The Johns Hopkins Hospital and Johns Hopkins University School of Medicine. He joined the faculty at Johns Hopkins in 1992 and is currently a Professor of Medicine/Cardiology. He was the past Director of the Adult Catheterization Laboratory and Interventional Cardiology at the Johns Hopkins Hospital. His field of specialization is management of coronary artery disease and valvular heart disease. Dr. Resar holds memberships in the American Heart Association and is a Fellow of the American College of Cardiology. Dr. Resar is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Errol L. Bush, M.D., FACS, is a thoracic surgeon and surgical director of the Advanced Lung Disease and Lung Transplant Program for the Johns Hopkins Comprehensive Transplant Center. He also serves as director of the Ex vivo Lung Perfusion Program (EVLP). Dr. Bush specializes in the surgical treatment of chronic and end stage lung diseases, as well as benign (non-cancerous) and malignant (cancerous) diseases and lesions of the chest. He is skilled in minimally invasive operations such as video-assisted thoracoscopic surgery (VATS), a type of thoracic surgery performed using a small video camera that is introduced into the patient's chest via a scope to treat lung and esophageal cancers. Dr. Bush also has experience with extracorporeal membrane oxygenation (ECMO), a technique of providing both cardiac and respiratory support oxygen to patients whose heart and lungs can no longer serve their function. His research interests include investigations of outcomes and health disparities related to lung cancer, lung transplant and ECMO patients. Dr. Bush is currently leading several open clinical trials. Dr. Bush is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Lung Cancer, Pulmonary Fibrosis, Fibrosing Mediastinitis, Lung Transplant, and Heart Transplant.

Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Multifocal Atrial Tachycardia, Cardiac Ablation, and Tissue Biopsy.

Mukta Srivastava is a Cardiologist in Baltimore,, Maryland. Dr. Srivastava is rated as an Advanced provider by MediFind in the treatment of Cardiogenic Shock. Her top areas of expertise are Apoplexy, Heart Attack, Cardiogenic Shock, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Stephen Gottlieb is a Cardiologist in Baltimore,, Maryland. Dr. Gottlieb is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Heart Failure, Cardiomyopathy, Apoplexy, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Albert Hicks is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Baltimore, Maryland. Dr. Hicks is rated as a Distinguished provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Cardiogenic Shock, Pulmonary Edema, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Endoscopy. Dr. Hicks is currently accepting new patients.